Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD

Respiratory Medicine

Volumn 105, Issue 12, 2011, Pages 1861-1871

  Yu, Andrew P ^a   Guérin, Annie ^a   De Leon, Diego Ponce ^a   Ramakrishnan, Karthik ^a   Wu, Eric Q ^a   Mocarski, Michelle ^b   Blum, Steven I ^b   Setyawan, Juliana ^b  

^a ANALYSIS GROUP   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

Author keywords

Combination therapies; COPD; Costs; Exacerbations; Resource utilization

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; METHYLXANTHINE; MUSCARINIC RECEPTOR BLOCKING AGENT;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG COST; EMERGENCY CARE; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INHALER; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MEDICATION ADHERENCE; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 81155133975     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.07.001     Document Type: Article

References (16)

1. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated 2010) 2010 http://www.goldcopd.com/Guidelineitem.asp?l1= 2&l2=1&intId=989 Accessed March 4th 11, 2011
2. American Lung Association Trends in COPD (Chronic Bronchitis and Emphysema): morbidity and mortality Report 2010 http://www.lungusa.org/finding- cures/for-professionals/epidemiology-and-statistics-rpts/copd-trend-report.pdf (Accessed 10.06.2010)
3. S. Hurd The impact of COPD on lung health worldwide: epidemiology and incidence Chest 117 2000 1S 4S (Pubitemid 30111555)
4. D.W. Brown, J.B. Croft, K.J. Greenlund, and W.H. Giles Trends in hospitalization with chronic obstructive pulmonary disease - United States, 1990-2005 Am J Respir Care Med 2009 179
5. National Heart Lung and Blood Institute. Morbidity and mortality: 2009 chart book on cardiovascular, lung, and blood diseases. http://www.nhlbi.nih. gov/resources/docs/2009-ChartBook.pdf. Accessed June 10, 2010.
6. D.E. O'Donnell, P. Hernandez, A. Kaplan, S. Aaron, J. Bourbeau, and D. Mariniuk Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care Can Respir J 15 Suppl.A 2008
7. B.D. Stein, J.T. Charbeneau, T.A. Lee, G.T. Schumock, P.K. Lindenauer, and D.S. Lauderdale Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how your count matters COPD 7 2010 164 171
8. A.P. Yu, H. Yang, E.Q. Wu, J. Setyawan, M. Mocarski, and S. Blum Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis J Med Econ 14 3 2011 315 323
9. F. Andersson, S. Borg, S.A. Jansson, A.C. Jonsson, A. Ericsson, and C. Prutz The costs of exacerbations in chronic obstructive pulmonary disease (COPD) Respir Med 96 2002 700 708
10. N. Mittmann, L. Kuramoto, S.J. Seung, J.M. Haddon, C. Bradley-Kennedy, and J.M. Fitzgerald The cost of moderate and severe COPD exacerbations to the Canadian healthcare system Respir Med 102 2008 413 421
11. J. Vestbo, J.A. Anderson, P.M. Calverley, Bartolome Celli, G.T. Ferguson, and C. Jenkins Adherence to inhaled therapy, mortality, and hospital admission in COPD Thorax 64 2009 939 943
12. J.C. Huestsh, E.M. Udris, and D.H. Au Predictors of adherence to inhaled medications in patients with COPD Am J Respir Care Med 181 2010 A3809
13. A.P. Yu, A. Guérin, D. Ponce de Leon, K. Ramakrishnan, E.Q. Wu, and M. Mocarski Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers J Med Econ 14 4 2011 486 496
14. J. Van Der Palen, J.J. Klein, C.L. van Herwaarden, G.A. Zielhuis, and E.R. Seydel Multiple inhalers confuse asthma patients Eur Respir J 14 1999 1034 1037
15. E. Chrischilles, D. Gilden, J. Kubisiak, L. Rubenstein, and H. Shah Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers Am J Manag Care 8 2002 902 911 (Pubitemid 35189758)
16. J. George, D.C. Kong, R. Thoman, and K. Stewart Factors associated with medication nonadherence in patients with COPD Chest 128 2005 3198 3204 (Pubitemid 41698641)